Development of a lorentz-force actuated intravitreal jet injector

Intravitreal injection is a common treatment in ophthalmology, but it can lead to numerous complications. Needle-free jet injection has been shown to successfully deliver fluid to various layers of skin, and, by its nature, may reduce intravitreal injection complications. From injection trials into ex vivo rabbit eyes, we find that needle-free jet injection can be used for intravitreal drug delivery. A custom-designed control scheme, characterized in this study, is crucial to this delivery. The system is capable of delivering 40 μL of fluid to the posterior vitreous humor, with an injection duration less than 100 ms and scleral entry site less than 350 μm in diameter.

[1]  Brian D. Hemond.  A Lorentz-force actuated controllable needle-free drug delivery system , 2006 .

[2]  J. D. Cameron,et al.  The use of 31-gauge needles and syringes for intraocular injections , 2007, Eye.

[3]  M E Zobitz,et al.  Scleral penetration force requirements for commonly used intravitreal needles , 2007, Eye.

[4]  T. Aslam,et al.  Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration. , 2009, Archives of ophthalmology.

[5]  Y. Tano,et al.  Complications in patients after intravitreal injection of bevacizumab , 2008, Acta ophthalmologica.

[6]  C. Pournaras,et al.  Current approach to postoperative endophthalmitis , 1997, The British journal of ophthalmology.

[7]  M. White,et al.  Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy. , 2006, American journal of ophthalmology.

[8]  Shulin Ding.  RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[9]  M. Cormier,et al.  A minimally invasive jet injector for intravitreal and subconjunctival injection. , 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[10]  Andrew Taberner,et al.  Needle-free jet injection using real-time controlled linear Lorentz-force actuators. , 2012, Medical engineering & physics.

[11]  S. Seregard,et al.  A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age‐related macular degeneration of different durations , 2008, Acta ophthalmologica.